ACE and diabetic kidney disease: The findings of this study confirm the significant heterogeneity of DKD in the course of T2DM and highlight the utility of molecular biomarkers (hsa-miR-126-3p, hsa-miR-423-5p), metabolic indices (AIP), and ACE concentration in differentiating clinical DKD phenotypes.